Clin2
NCT07748078Possibly a fitNot yet recruiting

Snoezelen therapy for adults with schizophrenia or alcohol dependence

SCHIZOPHRENIA 1 (Disorder)Alcohol Use DisorderAlcohol Dependence (Primary Condition)

Part of Mental health clinical trials.

This trial tests whether Snoezelen therapy — a relaxed, multi-sensory room experience — helps improve well-being in people with schizophrenia or alcohol dependence. It may be a calming addition to your usual care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
140 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are an adult (18+).
  • You have a confirmed diagnosis of schizophrenia (with mostly negative symptoms) or alcohol dependence (women only for alcohol group).
  • Your medication has been stable for at least 1–3 months.
  • You are able to understand and follow simple instructions.
  • You do not have active infections, uncontrolled epilepsy, cancer, certain neurological conditions, or (if female) pregnancy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07769749Not yet recruiting
Basal stimulation for adults with schizophrenia

This study tests whether basal stimulation therapy, a gentle sensory treatment, can improve well-being in older adults with schizophrenia. It may help with daily functioning and comfort.

Katowice, Silesian Voivodeship
NCT06444243Not yet recruiting· Phase 2
Psilocybin therapy for alcohol use disorder

This trial tests whether a psilocybin (magic mushroom) therapy session can help people with alcohol use disorder reduce their drinking. You'll have one or two guided sessions with a therapist, plus support before and after, to see if it helps you change your drinking habits.

NCT06405607Recruiting· Phase 2
Psilocybin vs Ketamine for Alcohol Use Disorder Trial

This trial tests two psychedelic-assisted therapies, psilocybin and ketamine, to see which works better for reducing heavy drinking in people with alcohol use disorder (AUD). You'll receive either drug along with counseling, and the study monitors safety closely.

Iowa City, Iowa
NCT07281261Recruiting
Nerve stimulation for alcohol use disorder

This study tests whether a mild nerve stimulation device (tAN) can help reduce alcohol cravings and withdrawal. It's for people with moderate to severe alcohol use disorder who are going through withdrawal and do not use tobacco.

Houston, Texas
NCT07296094Not yet recruiting· Phase 2
Psilocybin therapy for severe alcohol use disorder

This trial tests whether a single dose of psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help people with severe alcohol use disorder reduce or stop drinking. It's for people who've recently completed detox and are ready to commit to a structured program in Boston.

Boston, Massachusetts
NCT06894966Not yet recruiting
Ultrasound brain stimulation for alcohol use disorder

This study tests whether gentle ultrasound waves applied to the brain can help reduce heavy drinking. It involves six sessions and is for adults aged 21–55 with problematic alcohol use (high AUDIT scores).

Plymouth, Devon

Hear when a new SCHIZOPHRENIA 1 (Disorder) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.